Top Page
Talkspace
(NASDAQ:TALK)
Talkspace (TALK) vs. SPDR S&P 500 ETF (SPY)
Talkspace Business Overview & Revenue Model
Talkspace Earnings Call Summary
Talkspace Financial Statement Overview
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 228.87M | 187.59M | 150.04M | 119.57M | 113.67M |
| Gross Profit | 98.35M | 85.84M | 74.38M | 60.34M | 66.77M |
| EBITDA | 11.24M | 2.10M | -22.01M | -78.06M | -60.72M |
| Net Income | 7.79M | 1.15M | -19.18M | -79.67M | -62.74M |
Balance Sheet | |||||
| Total Assets | 134.86M | 138.68M | 142.22M | 156.25M | 223.61M |
| Cash, Cash Equivalents and Short-Term Investments | 92.59M | 117.81M | 123.91M | 138.54M | 198.26M |
| Total Debt | 0.00 | 0.00 | 0.00 | 500.00K | 0.00 |
| Total Liabilities | 17.85M | 21.28M | 23.57M | 28.72M | 31.33M |
| Stockholders Equity | 117.02M | 117.39M | 118.65M | 127.54M | 192.27M |
Cash Flow | |||||
| Free Cash Flow | -2.11M | 6.26M | -16.54M | -61.43M | -66.37M |
| Operating Cash Flow | 8.53M | 11.70M | -16.39M | -61.08M | -65.71M |
| Investing Cash Flow | -28.88M | -46.73M | -141.00K | -317.00K | -663.00K |
| Financing Cash Flow | -19.00M | -12.19M | 1.90M | 1.68M | 251.38M |
Talkspace Technical Analysis
Talkspace Risk Analysis
Talkspace Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $851.47M | 78.45 | 6.89% | ― | 18.37% | ― | |
59 Neutral | $2.47B | 281.23 | 0.65% | ― | 13.39% | 90.55% | |
58 Neutral | $613.45M | -0.99 | -172.50% | ― | ― | -21.62% | |
55 Neutral | $2.17B | ― | -39.42% | ― | 4.58% | -61.50% | |
55 Neutral | $304.77M | -2.77 | -24.30% | ― | -22.14% | -787.87% | |
54 Neutral | $1.62B | 11.03 | 19.58% | ― | -4.21% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Talkspace Corporate Events
On March 9, 2026, Talkspace agreed to be acquired by Universal Health Services in an all-cash merger that will see Talkspace become an indirect wholly owned subsidiary of UHS, with shareholders receiving $5.25 per share and the company’s stock delisted from the Nasdaq. The deal, unanimously approved by Talkspace’s board and supported by voting agreements covering roughly 14% of the stock, includes detailed treatment of equity awards and warrants, customary regulatory and shareholder approvals, no financing condition, and a $32.4 million termination fee if Talkspace backs a superior offer, underscoring UHS’s strategic push into digital mental health and signaling an exit from public markets for Talkspace investors.
The most recent analyst rating on (TALK) stock is a Hold with a $4.76 price target. To see the full list of analyst forecasts on Talkspace stock, see the TALK Stock Forecast page.
On March 9, 2026, Universal Health Services, Inc., one of the largest U.S. hospital and healthcare providers, agreed to acquire Talkspace, Inc., a Nasdaq-listed virtual behavioral health platform, for $5.25 per share in a deal valuing the target at about $835 million, financed via UHS’s existing revolving credit facility. The transaction, unanimously approved by both boards and expected to close in the third quarter of 2026 pending shareholder and regulatory approvals, is intended to create a nationally scaled, end-to-end behavioral health continuum, accelerate UHS’s outpatient and telehealth strategy, broaden its access to commercially insured populations, and is expected to be slightly accretive to adjusted earnings in the first year after closing.
The acquisition builds on Talkspace’s 2025 performance, when it generated $229 million in revenue and delivered more than 1.6 million therapy and psychiatry sessions through a 6,000-strong provider network serving over 200 million eligible individuals across all 50 states, D.C. and Puerto Rico. By integrating Talkspace’s virtual platform with UHS’s extensive network of inpatient and outpatient behavioral facilities, the deal is poised to expand access to mental healthcare, diversify UHS’s payor mix, and strengthen its competitive position in technology-enabled behavioral health services.
The most recent analyst rating on (TALK) stock is a Buy with a $5.50 price target. To see the full list of analyst forecasts on Talkspace stock, see the TALK Stock Forecast page.
On February 19, 2026, Talkspace reported fourth-quarter and full-year 2025 results showing strong top-line growth and improved profitability driven by its payor-focused virtual mental health services. Fourth-quarter revenue rose 29% year over year to $63.0 million, net income climbed to $4.8 million, and adjusted EBITDA reached $6.6 million, supported by a 36% increase in completed payor sessions and a 30% rise in unique active payor members.
For full-year 2025, revenue grew 22% to $228.9 million while net income surged to $7.8 million and adjusted EBITDA jumped 127% to $15.8 million, reflecting scaling of the payor channel despite a 30% decline in consumer revenue. Management highlighted record fourth-quarter momentum, ongoing network curation and deeper payor integrations, a solid year-end liquidity position, and the active beta of a proprietary AI agent, underscoring Talkspace’s strengthening position in digital behavioral health and its focus on sustainable, profitable growth.
The most recent analyst rating on (TALK) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Talkspace stock, see the TALK Stock Forecast page.
On January 15, 2026, Talkspace presented an investor deck at the 44th Annual J.P. Morgan Healthcare Conference outlining its growth trajectory, market opportunity and evolving product strategy. The company highlighted a large, underpenetrated U.S. behavioral health market, with strong demand across commercial, Medicare, military and teen segments, and reported approximately 24% compound annual revenue growth from 2022 to expected 2025 results, alongside a 115% year-on-year increase in adjusted EBITDA at the midpoint of its 2025 guidance. Management detailed a “systematic formula for growth” centered on diversified marketing, strategic payor and distribution partnerships, and patient journey optimization, which has driven higher checkout conversion and greater early-session engagement. Talkspace also underscored expansion moves including a dedicated psychiatry and medication management program, integration with Amazon Pharmacy, broader coverage for teens in major municipalities and state programs, national Tricare coverage and a direct Navy contract, as well as Medicare-covered services nationwide. Against the backdrop of growing use of general-purpose AI for mental health conversations, the company positioned its proprietary AI agent as a safer, clinically informed alternative designed specifically for mental health support, aiming to differentiate its technology and strengthen its position in the fast-evolving digital mental health landscape.
The most recent analyst rating on (TALK) stock is a Buy with a $4.50 price target. To see the full list of analyst forecasts on Talkspace stock, see the TALK Stock Forecast page.